Trial Profile
A Phase 1 Trial for Patients With Newly Diagnosed Anal Cancer Treated With Concurrent Radiation Therapy, 5FU, Mitomycin and BMX-001
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jan 2024
Price :
$35
*
At a glance
- Drugs BMX 001 (Primary) ; Fluorouracil; Mitomycin
- Indications Anal cancer; Squamous cell cancer
- Focus Adverse reactions
- 04 Jan 2024 Planned End Date changed from 1 Dec 2026 to 1 Dec 2029.
- 04 Jan 2024 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
- 23 Jan 2023 Planned End Date changed from 1 Dec 2024 to 1 Dec 2026.